世界における後天的遺伝子変異または後天的染色体変異検査製品のパイプライン動向2015...市場調査レポートについてご紹介

【英文タイトル】Acquired Gene or Chromosome Alterations - Pipeline Review, 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 17
2 Introduction 18
2.1 Acquired Gene or Chromosome Alterations Overview 18
3 Products under Development 19
3.1 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 19
3.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Territory 20
3.3 Acquired Gene or Chromosome Alterations – Pipeline Products by Regulatory Path 21
3.4 Acquired Gene or Chromosome Alterations – Pipeline Products by Estimated Approval Date 22
4 Acquired Gene or Chromosome Alterations – Pipeline Products under Development by Companies 23
4.1 Acquired Gene or Chromosome Alterations Companies – Pipeline Products by Stage of Development 23
4.2 Acquired Gene or Chromosome Alterations – Pipeline Products by Stage of Development 26
5 Acquired Gene or Chromosome Alterations Companies and Product Overview 36
5.1 Abbott Diagnostics Company Overview 36
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 36
5.2 Agendia NV Company Overview 177
5.2.1 Agendia NV Pipeline Products & Ongoing Clinical Trials Overview 177
5.3 AltheaDx, Inc. Company Overview 178
5.3.1 AltheaDx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 178
5.4 Amarantus Bioscience Holdings, Inc. Company Overview 181
5.4.1 Amarantus Bioscience Holdings, Inc. Pipeline Products & Ongoing Clinical Trials Overview 181
5.5 AstraZeneca Plc Company Overview 183
5.5.1 AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 183
5.6 AutoGenomics, Inc. Company Overview 185
5.6.1 AutoGenomics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 185
5.7 Biocept, Inc. Company Overview 186
5.7.1 Biocept, Inc. Pipeline Products & Ongoing Clinical Trials Overview 186
5.8 Cepheid Company Overview 189
5.8.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 189
5.9 Chinese University of Hong Kong Company Overview 192
5.9.1 Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 192
5.10 Columbia University Company Overview 194
5.10.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 194
5.11 Dana-Farber Cancer Institute, Inc. Company Overview 195
5.11.1 Dana-Farber Cancer Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 195
5.12 DiaCarta Company Overview 196
5.12.1 DiaCarta Pipeline Products & Ongoing Clinical Trials Overview 196
5.13 Exosome Diagnostics, Inc. Company Overview 197
5.13.1 Exosome Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 197
5.14 Gencurix Co., Ltd. Company Overview 198
5.14.1 Gencurix Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 198
5.15 GeneFirst Ltd Company Overview 199
5.15.1 GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview 199
5.16 GenMark Diagnostics, Inc. Company Overview 203
5.16.1 GenMark Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 203
5.17 Genomic Health, Inc. Company Overview 205
5.17.1 Genomic Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 205
5.18 Genomic Vision Company Overview 207
5.18.1 Genomic Vision Pipeline Products & Ongoing Clinical Trials Overview 207
5.19 GenomicTree, Inc. Company Overview 210
5.19.1 GenomicTree, Inc. Pipeline Products & Ongoing Clinical Trials Overview 210
5.20 German Cancer Research Center Company Overview 212
5.20.1 German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview 212
5.21 H. Lee Moffitt Cancer Center & Research Institute, Inc. Company Overview 214
5.21.1 H. Lee Moffitt Cancer Center & Research Institute, Inc. Pipeline Products & Ongoing Clinical Trials Overview 214
5.22 Harvard University Company Overview 216
5.22.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 216
5.23 Helmholtz Centre for Infection Research Company Overview 217
5.23.1 Helmholtz Centre for Infection Research Pipeline Products & Ongoing Clinical Trials Overview 217
5.24 HistoRx, Inc. (Inactive) Company Overview 218
5.24.1 HistoRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 218
5.25 Illumina, Inc. Company Overview 220
5.25.1 Illumina, Inc. Pipeline Products & Ongoing Clinical Trials Overview 220
5.26 Insight Genetics, Inc. Company Overview 223
5.26.1 Insight Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 223
5.27 InVivoScribe Technologies, Inc. Company Overview 225
5.27.1 InVivoScribe Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 225
5.28 Med BioGene Inc. Company Overview 226
5.28.1 Med BioGene Inc. Pipeline Products & Ongoing Clinical Trials Overview 226
5.29 Merrimack Pharmaceuticals, Inc. Company Overview 227
5.29.1 Merrimack Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 227
5.30 MolecularMD, Corp. Company Overview 229
5.30.1 MolecularMD, Corp. Pipeline Products & Ongoing Clinical Trials Overview 229
5.31 Multiplicom N.V. Company Overview 230
5.31.1 Multiplicom N.V. Pipeline Products & Ongoing Clinical Trials Overview 230
5.32 Myriad Genetics, Inc. Company Overview 231
5.32.1 Myriad Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 231
5.33 Nanosphere, Inc. Company Overview 234
5.33.1 Nanosphere, Inc. Pipeline Products & Ongoing Clinical Trials Overview 234
5.34 New York University Company Overview 237
5.34.1 New York University Pipeline Products & Ongoing Clinical Trials Overview 237
5.35 NIH Office of Technology Transfer Company Overview 238
5.35.1 NIH Office of Technology Transfer Pipeline Products & Ongoing Clinical Trials Overview 238
5.36 Oryzon Genomics S.A. Company Overview 240
5.36.1 Oryzon Genomics S.A. Pipeline Products & Ongoing Clinical Trials Overview 240
5.37 Oxford Biodynamics Limited Company Overview 241
5.37.1 Oxford Biodynamics Limited Pipeline Products & Ongoing Clinical Trials Overview 241
5.38 Panagene Inc. Company Overview 246
5.38.1 Panagene Inc. Pipeline Products & Ongoing Clinical Trials Overview 246
5.39 Pangaea Biotech, S.L. Company Overview 250
5.39.1 Pangaea Biotech, S.L. Pipeline Products & Ongoing Clinical Trials Overview 250
5.40 PDI, lnc. Company Overview 254
5.40.1 PDI, lnc. Pipeline Products & Ongoing Clinical Trials Overview 254
5.41 PharmaSeq, Inc. Company Overview 256
5.41.1 PharmaSeq, Inc. Pipeline Products & Ongoing Clinical Trials Overview 256
5.42 Qiagen N.V. Company Overview 258
5.42.1 Qiagen N.V. Pipeline Products & Ongoing Clinical Trials Overview 258
5.43 RedPath Integrated Pathology, Inc. Company Overview 268
5.43.1 RedPath Integrated Pathology, Inc. Pipeline Products & Ongoing Clinical Trials Overview 268
5.44 Response Genetics, Inc. Company Overview 269
5.44.1 Response Genetics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 269
5.45 Rheonix, Inc. Company Overview 272
5.45.1 Rheonix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 272
5.46 Seegene, Inc. Company Overview 274
5.46.1 Seegene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 274
5.47 Shuwen Biotech Co. Ltd. Company Overview 276
5.47.1 Shuwen Biotech Co. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 276
5.48 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 284
5.48.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 284
5.49 Sygnis AG Company Overview 288
5.49.1 Sygnis AG Pipeline Products & Ongoing Clinical Trials Overview 288
5.50 Sysmex Corporation Company Overview 290
5.50.1 Sysmex Corporation Pipeline Products & Ongoing Clinical Trials Overview 290
5.51 The Johns Hopkins University Company Overview 292
5.51.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 292
5.52 thromboDx Company Overview 294
5.52.1 thromboDx Pipeline Products & Ongoing Clinical Trials Overview 294
5.53 Transbiomed, SL Company Overview 296
5.53.1 Transbiomed, SL Pipeline Products & Ongoing Clinical Trials Overview 296
5.54 Transgenomic, Inc. Company Overview 297
5.54.1 Transgenomic, Inc. Pipeline Products & Ongoing Clinical Trials Overview 297
5.55 TrovaGene, Inc. Company Overview 299
5.55.1 TrovaGene, Inc. Pipeline Products & Ongoing Clinical Trials Overview 299
5.56 University of California, Irvine Company Overview 301
5.56.1 University of California, Irvine Pipeline Products & Ongoing Clinical Trials Overview 301
5.57 Vela Diagnostics Company Overview 302
5.57.1 Vela Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 302
5.58 Xiamen Zeesan Biotech Co.,Ltd Company Overview 307
5.58.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 307
6 Acquired Gene or Chromosome Alterations- Recent Developments 311
7 Appendix 345
7.1 Methodology 345
7.2 About GlobalData 347
7.3 Contact Us 348
7.4 Disclaimer 348


【レポート販売概要】

■ タイトル:世界における後天的遺伝子変異または後天的染色体変異検査製品のパイプライン動向2015
■ 英文:Acquired Gene or Chromosome Alterations - Pipeline Review, 2015
■ 発行日:2015年10月1日
■ 調査会社:GlobalData
■ 商品コード:GDME0077EPD
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。